Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coviccine Global Phase 3 Trial
NCT04904471Phase 3Completed
- Sponsor
- WestVac Biopharma
- Start
- Jun 2021
- Primary completion
- Jan 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 3 trial of recombinant COVID-19 (XBB) trimer protein vaccine in coronavirus disease 2019 (COVID-19), sponsored by WestVac Biopharma. Started Jun 2021; status: completed.
02
Drugs
recombinant COVID-19 (XBB) trimer protein vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04904471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04904471.